Stockreport

Reata Pharmaceuticals Just Raised $505 Million to Treat Orphan Diseases: What it Means for Investors [The Motley Fool]

Reata Pharmaceuticals, Inc. - Class A  (RETA) 
Last reata pharmaceuticals, inc. - class a earnings: 2/19 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.reatapharma.com
PDF Reata Pharmaceuticals Just Raised $505 Million to Treat Orphan Diseases: What it Means for Investors The capital sets the biotech up nicely to launch two successful drug [Read more]